Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review

As of August 16, 2021, there have been 207,173,086 confirmed cases and 4,361,996 deaths due to the coronavirus disease (COVID-19), and the pandemic remains a global challenge. To date, no effective and approved drugs are available for the treatment of COVID-19. Angiotensin-converting enzyme 2 (ACE2)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bhagat Singh, Dheer Singh, Vinod Verma, Ramakant Yadav, Raj Kumar
Format: Artigo
Langue:Inglês
Publié: Elsevier 2022-04-01
Collection:Journal of Pharmaceutical Analysis
Sujets:
COVID-19
ACE2 receptors
hrsACE2
ACE inhibitors
RAS
AT1R blocker
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S2095177921001465
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires